FIELD: laboratory diagnostics; physiology; immunology.
SUBSTANCE: invention is intended to predict the effector deficiency of cytotoxic cells by increasing the concentrations of molecules sCD54, sCD56, sCD71. In the peripheral venous blood of the examined individuals, the concentrations of sCD54, sCD56, sCD71 are determined. With a simultaneous increase in the concentrations of sCD54>300 ng/ml, sCD56>20 ng/ml and sCD71>1,900 ng/ml, a high level of risk is predicted — 95% of effector failure of cytotoxic cells.
EFFECT: invention makes it possible to identify individuals at risk of cancer, intracellular infections, infectious allergies and autoimmune diseases.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE OF LEIOMYOMA GROWTH PATTERNS | 2013 |
|
RU2542468C1 |
| METHOD FOR PRODUCTION OF IN VITRO POPULATIONS OF ACTIVATED ANTIGENSPECIFIC ANTITUMOR-TUMOR CYTOTOXIC T-LYMPHOCYTES SPECIFIC TO TUMOR-ASSOCIATED ANTIGEN EPITOPES | 2016 |
|
RU2619186C1 |
| COMBINED CELL TRANSPLANT BASED ON LYMPHOKINE-ACTIVATED KILLERS AND DENDRITE CELLS, METHOD FOR PRODUCTION THEREOF AND METHOD FOR TREATMENT AND PROPHYLAXIS OF MALIGNANT, INFECTIVE DISEASES AND IMMUNODEFICIENT CONDITIONS | 2006 |
|
RU2309753C1 |
| METHOD OF PRODUCING ANTIGEN-SPECIFIC CYTOTOXIC CELLS HAVING ACTIVITY AGAINST BREAST CANCER CELLS | 2013 |
|
RU2596920C2 |
| METHOD FOR PREDICTING RISK OF MALIGNANT NEW GROWTHS | 2014 |
|
RU2552305C1 |
| AUTOLOGOUS VACCINE FOR ONCOTHERAPY AND METHOD FOR PREPARING THEREOF | 2008 |
|
RU2392946C2 |
| BI- OR MULTISPECIFIC POLYPEPTIDES BINDING IMMUNE EFFECTOR CELL SURFACE ANTIGENS AND HBV ANTIGENS FOR TREATMENT OF BV INFECTIONS AND ASSOCIATED CONDITIONS | 2014 |
|
RU2671089C2 |
| METHOD FOR PREDICTION OF SEVERE HAEMORRHAGIC FEVER WITH RENAL SYNDROME AT EARLY STAGES OF DISEASE | 2022 |
|
RU2790962C1 |
| METHOD FOR PRODUCING HUMAN T-CELL RECEPTOR SPECIFIC TO EPITOPE 112-120 (KVAELVHFL) OF MAGE-A3 RECEPTOR | 2024 |
|
RU2840503C1 |
| METHOD FOR DIAGNOSING PROLIFERATIVE ACTIVITY OF UTERINE LEIOMYOMA CELLS | 2019 |
|
RU2700003C1 |
